{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T19:46:31Z","timestamp":1793303191234,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T00:00:00Z","timestamp":1748044800000},"content-version":"am","delay-in-days":327,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.jconrel.2024.05.037","type":"journal-article","created":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T09:51:41Z","timestamp":1716544301000},"page":"101-110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Hypotonic, gel-forming delivery system for vaginal drug administration"],"prefix":"10.1016","volume":"371","author":[{"given":"Rachel L.","family":"Shapiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly M.","family":"Bockley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry T.","family":"Hsueh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew B.","family":"Appell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davell M.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jairo","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cory","family":"Brayton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura M.","family":"Ensign","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2024.05.037_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114132","article-title":"Advances in drug delivery for women\u2019s health: a matter of gender equity","volume":"182","author":"das Neves","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.jconrel.2024.05.037_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s42379-023-00130-7","article-title":"Understanding the global dynamics of continuing unmet need for family planning and unintended pregnancy","volume":"7","author":"Coulson","year":"2023","journal-title":"China Popul. Dev. Stud."},{"issue":"3","key":"10.1016\/j.jconrel.2024.05.037_bb0015","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2016-000080","article-title":"Women\u2019s health: a new global agenda","volume":"1","author":"Peters","year":"2016","journal-title":"BMJ Glob. Health"},{"issue":"3","key":"10.1016\/j.jconrel.2024.05.037_bb0020","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/17425247.2020.1728251","article-title":"Vaginal multipurpose prevention technologies: promising approaches for enhancing women\u2019s sexual and reproductive health","volume":"17","author":"Fernandes","year":"2020","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2024.05.037_bb0025","series-title":"Mucoadhesive Materials and Drug Delivery Systems","article-title":"Vaginal mucosa and drug delivery","author":"Jos\u00e9 das Neves","year":"2014"},{"key":"10.1016\/j.jconrel.2024.05.037_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114133","article-title":"Women\u2019s preferences and acceptance for different drug delivery routes and products","volume":"182","author":"Palmeira-de-Oliveira","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.jconrel.2024.05.037_bb0035","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0015-0282(01)01822-2","article-title":"Distribution of topical medication in the human vagina as imaged by magnetic resonance imaging","volume":"76","author":"Barnhart","year":"2001","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jconrel.2024.05.037_bb0040","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1749-6632.1960.tb40886.x","article-title":"The gross and microscopic anatomy of the human vagina","volume":"83","author":"Krantz","year":"1959","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"6","key":"10.1016\/j.jconrel.2024.05.037_bb0045","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.contraception.2004.06.013","article-title":"In vivo distribution of a vaginal gel: MRI evaluation of the effects of gel volume, time and simulated intercourse","volume":"70","author":"Barnhart","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.jconrel.2024.05.037_bb0050","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jconrel.2014.04.033","article-title":"Nanoparticle-based drug delivery to the vagina: a review","volume":"190","author":"Ensign","year":"2014","journal-title":"J. Control. Release"},{"issue":"28","key":"10.1016\/j.jconrel.2024.05.037_bb0055","doi-asserted-by":"crossref","first-page":"6922","DOI":"10.1016\/j.biomaterials.2013.05.039","article-title":"Enhanced vaginal drug delivery through the use of hypotonic formulations that induce fluid uptake","volume":"34","author":"Ensign","year":"2013","journal-title":"Biomaterials"},{"issue":"11","key":"10.1016\/j.jconrel.2024.05.037_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048328","article-title":"Is wetter better? An evaluation of over-the-counter personal lubricants for safety and anti-HIV-1 activity","volume":"7","author":"Dezzutti","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2024.05.037_bb0065","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.toxrep.2017.12.011","article-title":"Hyperosmolal vaginal lubricants markedly reduce epithelial barrier properties in a three-dimensional vaginal epithelium model","volume":"5","author":"Ayehunie","year":"2018","journal-title":"Toxicol. Rep."},{"key":"10.1016\/j.jconrel.2024.05.037_bb0070","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1186\/1471-2334-10-331","article-title":"Microbicide excipients can greatly increase susceptibility to genital herpes transmission in the mouse","volume":"10","author":"Moench","year":"2010","journal-title":"BMC Infect. Dis."},{"issue":"576","key":"10.1016\/j.jconrel.2024.05.037_bb0075","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abc6245","article-title":"Enhanced drug delivery to the reproductive tract using nanomedicine reveals therapeutic options for prevention of preterm birth","volume":"13","author":"Zierden","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2024.05.037_bb0080","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jconrel.2018.12.046","article-title":"Development of a mucoinert progesterone nanosuspension for safer and more effective prevention of preterm birth","volume":"295","author":"Hoang","year":"2019","journal-title":"J. Control. Release"},{"issue":"11","key":"10.1016\/j.jconrel.2024.05.037_bb0085","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/s41551-020-00606-8","article-title":"Gelling hypotonic polymer solution for extended topical drug delivery to the eye","volume":"4","author":"Kim","year":"2020","journal-title":"Nat. Biomed. Eng."},{"issue":"7","key":"10.1016\/j.jconrel.2024.05.037_bb0090","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1016\/j.fertnstert.2010.02.033","article-title":"Crinone vaginal gel is equally effective and better tolerated than intramuscular progesterone for luteal phase support in in vitro fertilization-embryo transfer cycles: a prospective randomized study","volume":"94","author":"Yanushpolsky","year":"2010","journal-title":"Fertil. Steril."},{"issue":"5","key":"10.1016\/j.jconrel.2024.05.037_bb0095","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0015-0282(99)00362-3","article-title":"Use of Crinone vaginal progesterone gel for luteal support in in vitro fertilization cycles","volume":"72","author":"Chantilis","year":"1999","journal-title":"Fertil. Steril."},{"issue":"7","key":"10.1016\/j.jconrel.2024.05.037_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/ma12071083","article-title":"Injectable hydrogels based on pluronic\/water systems filled with alginate microparticles for biomedical applications","volume":"12","author":"Cidade","year":"2019","journal-title":"Materials (Basel)"},{"issue":"1","key":"10.1016\/j.jconrel.2024.05.037_bb0105","doi-asserted-by":"crossref","first-page":"11658","DOI":"10.1038\/s41598-019-48254-6","article-title":"Dual-responsive (pH\/temperature) Pluronic F-127 hydrogel drug delivery system for textile-based transdermal therapy","volume":"9","author":"Chatterjee","year":"2019","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.jconrel.2024.05.037_bb0110","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1208\/s12249-013-9983-8","article-title":"Development and validation of a HPLC method for dissolution and stability assay of liquid-filled cyclosporine capsule drug products","volume":"14","author":"Xu","year":"2013","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2024.05.037_bb0115","series-title":"Guide for the Care and Use of Laboratory Animals","year":"2011"},{"issue":"4","key":"10.1016\/j.jconrel.2024.05.037_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035538","article-title":"Mouse estrous cycle identification tool and images","volume":"7","author":"Byers","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jconrel.2024.05.037_bb0125","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jconrel.2011.08.032","article-title":"A poly(ethylene glycol)-based surfactant for formulation of drug-loaded mucus penetrating particles","volume":"157","author":"Mert","year":"2012","journal-title":"J. Control. Release"},{"issue":"6","key":"10.1016\/j.jconrel.2024.05.037_bb0130","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1021\/mp400087y","article-title":"Ex vivo characterization of particle transport in mucus secretions coating freshly excised mucosal tissues","volume":"10","author":"Ensign","year":"2013","journal-title":"Mol. Pharm."},{"issue":"2","key":"10.1016\/j.jconrel.2024.05.037_bb0135","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1073\/pnas.0911748107","article-title":"Nanoparticles reveal that human cervicovaginal mucus is riddled with pores larger than viruses","volume":"107","author":"Lai","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"27","key":"10.1016\/j.jconrel.2024.05.037_bb0140","doi-asserted-by":"crossref","first-page":"4893","DOI":"10.1016\/S0142-9612(03)00404-6","article-title":"Galactosylated PVDF membrane promotes hepatocyte attachment and functional maintenance","volume":"24","author":"Lu","year":"2003","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.jconrel.2024.05.037_bb0145","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ajpath.2019.10.013","article-title":"Characterization of an adapted murine model of intrauterine inflammation-induced preterm birth","volume":"190","author":"Zierden","year":"2020","journal-title":"Am. J. Pathol."},{"issue":"21","key":"10.1016\/j.jconrel.2024.05.037_bb0150","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1002\/adhm.201600599","article-title":"Mucus-penetrating Nanosuspensions for enhanced delivery of poorly soluble drugs to mucosal surfaces","volume":"5","author":"Yu","year":"2016","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2024.05.037_bb0155","series-title":"Crinone\u00ae 4% and Crinone\u00ae 8%, (progesterone gel) PHYSICIAN INFORMATION","author":"FDA, U","year":"2013"},{"key":"10.1016\/j.jconrel.2024.05.037_bb0160","article-title":"The female vaginal microbiome in health and bacterial vaginosis","volume":"11","author":"Chen","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"1","key":"10.1016\/j.jconrel.2024.05.037_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008236","article-title":"The cervicovaginal mucus barrier to HIV-1 is diminished in bacterial vaginosis","volume":"16","author":"Hoang","year":"2020","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jconrel.2024.05.037_bb0170","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1749-6632.1997.tb48550.x","article-title":"The first uterine pass effect","volume":"828","author":"De Ziegler","year":"1997","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"5","key":"10.1016\/j.jconrel.2024.05.037_bb0175","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.molmed.2020.12.001","article-title":"Avoiding a sticky situation: bypassing the mucus barrier for improved local drug delivery","volume":"27","author":"Zierden","year":"2021","journal-title":"Trends Mol. Med."},{"issue":"4","key":"10.1016\/j.jconrel.2024.05.037_bb0180","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00192-012-2009-3","article-title":"The vagina as a route for drug delivery: a review","volume":"24","author":"Srikrishna","year":"2013","journal-title":"Int. Urogynecol. J."},{"issue":"3","key":"10.1016\/j.jconrel.2024.05.037_bb0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150896","article-title":"Drivers of vaginal drug delivery system acceptability from internet-based conjoint analysis","volume":"11","author":"Primrose","year":"2016","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.jconrel.2024.05.037_bb0190","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S1461-5347(00)00296-0","article-title":"The scope and potential of vaginal drug delivery","volume":"3","author":"Vermani","year":"2000","journal-title":"Pharm. Sci. Technol. Today"},{"issue":"1","key":"10.1016\/j.jconrel.2024.05.037_bb0195","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ejps.2012.06.001","article-title":"Post-expansile hydrogel foam aerosol of PG-liposomes: a novel delivery system for vaginal drug delivery applications","volume":"47","author":"Li","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2024.05.037_bb0200","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ijpharm.2008.08.021","article-title":"Microemulsion based vaginal gel of fluconazole: formulation, in vitro and in vivo evaluation","volume":"365","author":"Bachhav","year":"2009","journal-title":"Int. J. Pharm."},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2024.05.037_bb0205","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ijpharm.2011.02.025","article-title":"The effect of polymeric additives on the solubilisation of a poorly-soluble drug in micellar solutions of Pluronic F127","volume":"409","author":"Oliveira","year":"2011","journal-title":"Int. J. Pharm."},{"issue":"8","key":"10.1016\/j.jconrel.2024.05.037_bb0210","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1080\/03639045.2017.1313857","article-title":"Improved solubility and oral bioavailability of apigenin via Soluplus\/Pluronic F127 binary mixed micelles system","volume":"43","author":"Zhang","year":"2017","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2024.05.037_bb0215","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.molliq.2018.11.060","article-title":"Impact of pluronic F127 on aqueous solubility and membrane permeability of antirheumatic compounds of different structure and polarity","volume":"274","author":"Mikhail Agafonov","year":"2019","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.jconrel.2024.05.037_bb0220","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.biomaterials.2018.09.005","article-title":"Mucus-penetrating budesonide nanosuspension enema for local treatment of inflammatory bowel disease","volume":"185","author":"Date","year":"2018","journal-title":"Biomaterials"},{"issue":"12","key":"10.1016\/j.jconrel.2024.05.037_bb0225","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1007\/s11095-006-9104-4","article-title":"A review of poloxamer 407 pharmaceutical and pharmacological characteristics","volume":"23","author":"Dumortier","year":"2006","journal-title":"Pharm. Res."},{"issue":"12","key":"10.1016\/j.jconrel.2024.05.037_bb0230","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.1021\/bm501419z","article-title":"Pretreatment of human cervicovaginal mucus with pluronic F127 enhances nanoparticle penetration without compromising mucus barrier properties to herpes simplex virus","volume":"15","author":"Ensign","year":"2014","journal-title":"Biomacromolecules"},{"issue":"42","key":"10.1016\/j.jconrel.2024.05.037_bb0235","doi-asserted-by":"crossref","first-page":"10834","DOI":"10.1021\/jp014221i","article-title":"Temperature-dependent adsorption of pluronic F127 block copolymers onto carbon black particles dispersed in aqueous media","volume":"106","author":"Alexandridis","year":"2002","journal-title":"J. Phys. Chem. B"},{"issue":"1","key":"10.1016\/j.jconrel.2024.05.037_bb0240","doi-asserted-by":"crossref","DOI":"10.3390\/jfb9010011","article-title":"Formulation of poloxamers for drug delivery","volume":"9","author":"Bodratti","year":"2018","journal-title":"J. Funct. Biomater."},{"issue":"1","key":"10.1016\/j.jconrel.2024.05.037_bb0245","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0378-5173(02)00232-6","article-title":"Rheological evaluation of thermosensitive and mucoadhesive vaginal gels in physiological conditions","volume":"241","author":"Chang","year":"2002","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.jconrel.2024.05.037_bb0250","doi-asserted-by":"crossref","first-page":"E54","DOI":"10.1208\/pt070254","article-title":"Fluid bed drying of guarana (Paullinia cupana HBK) extract: effect of process factors on caffeine content","volume":"7","author":"Pagliarussi","year":"2006","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2024.05.037_bb0255","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.diff.2019.07.004","article-title":"Reproductive tract biology: of mice and men","volume":"110","author":"Cunha","year":"2019","journal-title":"Differentiation"},{"key":"10.1016\/j.jconrel.2024.05.037_bb0260","series-title":"Comparative Anatomy and Histology, A Mouse and Human Atlas","first-page":"253","article-title":"Female reproductive system","author":"Rendi","year":"2012"},{"key":"10.1016\/j.jconrel.2024.05.037_bb0265","series-title":"Female Reproductive System, in Comparative Anatomy and Histology: A Mouse, Rat, and Human Atlas","first-page":"303","author":"Boyd","year":"2018"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924003225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924003225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T06:09:21Z","timestamp":1719295761000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365924003225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":53,"alternative-id":["S0168365924003225"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.05.037","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypotonic, gel-forming delivery system for vaginal drug administration","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.05.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}